nodes	percent_of_prediction	percent_of_DWPC	metapath
Topotecan—Heartburn—Hydrochlorothiazide—nephrolithiasis	0.0657	0.0657	CcSEcCtD
Topotecan—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.0472	0.0472	CcSEcCtD
Topotecan—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.0296	0.0296	CcSEcCtD
Topotecan—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0296	0.0296	CcSEcCtD
Topotecan—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0289	0.0289	CcSEcCtD
Topotecan—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.0265	0.0265	CcSEcCtD
Topotecan—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.0258	0.0258	CcSEcCtD
Topotecan—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.0254	0.0254	CcSEcCtD
Topotecan—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0248	0.0248	CcSEcCtD
Topotecan—Sweating—Hydrochlorothiazide—nephrolithiasis	0.0242	0.0242	CcSEcCtD
Topotecan—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.0239	0.0239	CcSEcCtD
Topotecan—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.0228	0.0228	CcSEcCtD
Topotecan—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0226	0.0226	CcSEcCtD
Topotecan—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.0225	0.0225	CcSEcCtD
Topotecan—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.0201	0.0201	CcSEcCtD
Topotecan—Back pain—Hydrochlorothiazide—nephrolithiasis	0.0191	0.0191	CcSEcCtD
Topotecan—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.019	0.019	CcSEcCtD
Topotecan—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.0183	0.0183	CcSEcCtD
Topotecan—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.0183	0.0183	CcSEcCtD
Topotecan—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.0181	0.0181	CcSEcCtD
Topotecan—Malaise—Hydrochlorothiazide—nephrolithiasis	0.0178	0.0178	CcSEcCtD
Topotecan—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.0177	0.0177	CcSEcCtD
Topotecan—Cough—Hydrochlorothiazide—nephrolithiasis	0.0172	0.0172	CcSEcCtD
Topotecan—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.0168	0.0168	CcSEcCtD
Topotecan—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.0168	0.0168	CcSEcCtD
Topotecan—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.0168	0.0168	CcSEcCtD
Topotecan—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.0166	0.0166	CcSEcCtD
Topotecan—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.0161	0.0161	CcSEcCtD
Topotecan—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.0158	0.0158	CcSEcCtD
Topotecan—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.0156	0.0156	CcSEcCtD
Topotecan—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.0154	0.0154	CcSEcCtD
Topotecan—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.0147	0.0147	CcSEcCtD
Topotecan—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.0145	0.0145	CcSEcCtD
Topotecan—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0144	CcSEcCtD
Topotecan—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.0142	0.0142	CcSEcCtD
Topotecan—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.014	0.014	CcSEcCtD
Topotecan—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.0139	0.0139	CcSEcCtD
Topotecan—Pain—Hydrochlorothiazide—nephrolithiasis	0.0138	0.0138	CcSEcCtD
Topotecan—Constipation—Hydrochlorothiazide—nephrolithiasis	0.0138	0.0138	CcSEcCtD
Topotecan—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.0133	0.0133	CcSEcCtD
Topotecan—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.0132	0.0132	CcSEcCtD
Topotecan—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0128	CcSEcCtD
Topotecan—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0128	CcSEcCtD
Topotecan—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0128	CcSEcCtD
Topotecan—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0119	CcSEcCtD
Topotecan—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0116	CcSEcCtD
Topotecan—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0114	CcSEcCtD
Topotecan—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.011	0.011	CcSEcCtD
Topotecan—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0107	CcSEcCtD
Topotecan—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0103	CcSEcCtD
Topotecan—Rash—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0102	CcSEcCtD
Topotecan—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0102	CcSEcCtD
Topotecan—Headache—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0101	CcSEcCtD
Topotecan—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00958	0.00958	CcSEcCtD
